Malperfusion sharply worsens early survival after type A aortic dissection surgery
In a large Asian multicenter cohort, type A aortic dissection accompanied by malperfusion syndrome carried a clear early hazard after open repair. Among 1,021 surgically treated patients from 2002 to 2018, 209 arrived with preoperative malperfusion and 812 did not. The difference in outcomes was concentrated in the first month after surgery, when the physiologic cost of ischemic organ injury, emergency cardiothoracic reconstruction, and postoperative instability is highest.
The 30-day mortality signal was difficult to ignore. Death occurred in 28.7% of patients with malperfusion compared with 15.8% without it, and the adjusted odds ratio was 1.93, with a 95% confidence interval of 1.32 to 2.84. In practical terms, the presence of malperfusion nearly doubled the odds of early death even after accounting for other factors in the analysis. Aortic dissection is already a time-sensitive emergency; once branch-vessel obstruction adds cerebral, renal, visceral, or limb ischemia, the operation begins from a far less forgiving physiologic baseline.
Why ischemia changes the surgical risk profile
Malperfusion in acute dissection reflects more than a blocked vessel. It signals ongoing end-organ injury before the chest is even opened, and that injury can continue through reperfusion, bypass, and postoperative recovery. Ischemic tissues are more vulnerable to acidosis, inflammatory activation, and reperfusion-related dysfunction, which helps explain why the early postoperative period separated the cohorts so clearly. Surgery can restore flow, but it cannot fully erase preoperative hypoperfusion, especially when the brain is already affected.
Overall mortality from surgery followed the same pattern. Patients with malperfusion had a 34.4% mortality rate versus 24.0% in those without malperfusion, with an adjusted hazard ratio of 1.36 and a 95% confidence interval of 1.01 to 1.83. The excess risk did not persist in the same way after discharge. Mortality from discharge onward was not significantly different between groups, with an adjusted hazard ratio of 0.84 and a wide confidence interval of 0.40 to 1.77. The signal therefore appears front-loaded: the dangerous window is the perioperative and early recovery phase rather than the longer outpatient course.
Cerebral malperfusion carried the highest early penalty
Among the different malperfusion patterns, cerebral malperfusion stood out. Within single-organ malperfusion, cerebral involvement was associated with 30-day mortality, with an adjusted odds ratio of 2.25 and a 95% confidence interval of 1.08 to 4.70. Brain ischemia in the setting of dissection is especially perilous because neurologic injury may already be advanced by the time definitive repair begins. Even when perfusion is restored, preexisting cerebral insult can drive poor early neurologic and systemic outcomes.
Single-organ malperfusion overall was also associated with higher 30-day mortality than no malperfusion, with an adjusted odds ratio of 1.86 and a 95% confidence interval of 1.23 to 2.86. Two-organ malperfusion showed a numerically higher risk but did not reach statistical significance, with an adjusted odds ratio of 1.66 and a 95% confidence interval of 0.76 to 3.66. The broader message is not that two-organ disease is benign; it is that the early mortality burden was most consistently detectable when malperfusion was present, and most clearly when the brain was involved.
Preoperative triage should treat cerebral involvement as a red flag
For surgeons, anesthesiologists, and emergency teams, these data argue for a more aggressive front-end risk appraisal when malperfusion is suspected. Computed tomography, magnetic resonance imaging, and other perfusion assessments already help define the anatomy of dissection, but the presence of end-organ compromise should now be viewed as a major prognostic input, not a descriptive add-on. Cerebral malperfusion deserves particular attention because it marks a group with steep early mortality despite operative treatment.
The study used a retrospective design and relied on data from 1021 patients across Asian institutions, which gives the findings breadth while still reflecting a real-world surgical population. The strength lies in the size of the cohort and the separation of early from later outcomes. The limitation lies in what retrospective surgical series cannot fully capture: exact timing of ischemia, subtle differences in operative strategy, and the full severity of end-organ injury at presentation. Even so, the survival pattern is consistent enough to inform bedside judgment.
Early risk, not late fate, was where malperfusion mattered most.
The prognostic question narrows to the first postoperative days
The lack of a significant mortality difference after discharge changes how this cohort should be read. It suggests that if patients with malperfusion survive the operation and immediate recovery, their longer-term survival may converge with that of patients who did not present with organ ischemia. In other words, the danger is concentrated at the front end of care, where triage, operative timing, circulatory support, and neurologic assessment are all decisive.
This pattern has direct clinical consequences. Teams managing acute type A aortic dissection should treat malperfusion as an urgent marker of vulnerability, and cerebral malperfusion as a particularly high-risk presentation. The findings do not question surgery; open repair remains the definitive treatment in this setting. They do, however, sharpen the preoperative conversation around prognosis and resource intensity, especially in patients whose brain has already been deprived of blood flow before the first incision is made.